Inotiv在通报中称："2025年8月8日，Inotiv公司发现一起影响部分系统和数据的网络安全事件。" "初步调查显示，一名威胁行为者未经授权访问并加密了公司部分系统。" 目前，Inotiv已在外部安全专家的协助下展开调查，并已将事件上报执法部门。麒麟（Qilin）勒索软件 团伙声称对此次攻击事件负责。该组织表示已窃取约16.2万个文件，总计176GB，并在其泄露网站上公 开发布了部分数据样本。 Inotiv是一家研究外包公司，总部位于美国印第安纳州。其主要业务包括药物开发、药物发现与安全性 评估，以及活体动物研究建模。 该公司拥有约2000名专业人员，年收入超过5亿美元。 来源：市场资讯 （来源：奇安信） 勒索软件团伙声称窃取了Inotiv公司176GB数据，共计约16.2万个文件，并在网站上公开了部分数据样 本。 安全内参8月21日消息，美国制药公司Inotiv披露称，其部分系统和数据在一次勒索软件攻击中被加密， 导致公司业务运营受到影响。 在提交给美国证券交易委员会（SEC）的文件中，Inotiv表示此次网络攻击发生在8月8日，公司已采取 措施控制漏洞。 公司表示，此次网络安全事件导致部分业务运营受 ...

Core Points - The company, He Yuan Biotechnology (Shanghai) Co., Ltd., was established as a joint-stock company in accordance with the Company Law of the People's Republic of China and is registered with the Shanghai Municipal Market Supervision Administration [1][2] - The company was approved by the Shanghai Stock Exchange on November 4, 2021, and registered with the China Securities Regulatory Commission on January 11, 2022, for its initial public offering of 100 million shares, which were listed on the STAR Market on March 22, 2022 [2] - The registered capital of the company is RMB 649.0367 million [2] - The company aims to develop high-tech industries and expand both domestic and international markets while ensuring reasonable returns for shareholders and creating positive social effects [6] Company Structure - The company is a permanent joint-stock company, with the board of directors acting as the legal representative [2][3] - The legal representative is responsible for civil activities conducted in the company's name, and the company bears civil liability for actions taken by the legal representative [3] - Shareholders are liable for the company's debts only to the extent of their subscribed shares, while the company is liable for its debts with all its assets [3] Business Operations - The company's business scope includes drug production, entrusted drug production, and various technical services in the biomedical field [6] - The company operates under principles of honesty and legality, aiming to optimize management and develop high-tech industries [6] Share Issuance and Management - The company issues registered shares, all of which are ordinary shares, with a total of 649.0367 million shares issued [7] - The shares are stored in a centralized manner at the Shanghai branch of China Securities Depository and Clearing Corporation Limited [7] - The company can increase its registered capital through various methods, including issuing shares to unspecified or specific objects, subject to shareholder approval [9] Shareholder Rights and Responsibilities - Shareholders have rights to dividends, voting, and other benefits proportional to their shareholdings [15] - Shareholders are required to comply with laws and the company's articles of association, and they cannot withdraw their capital except as permitted by law [20] - The company has provisions for shareholders to propose and vote on various matters, including the election of directors and approval of financial reports [23][29] Governance and Meetings - The company holds annual and extraordinary shareholder meetings, with specific procedures for calling and conducting these meetings [48][52] - The board of directors is responsible for convening shareholder meetings and ensuring compliance with legal and regulatory requirements [52][54] - Shareholder meetings must be documented, and records must be maintained for a minimum of 10 years [78]